These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 20843289

  • 1. New synthesis of tic-hydantoins sigma-1 ligands and pharmacological evaluation on cocaine-induced stimulant effects.
    Toussaint M, Debreu-Fontaine MA, Maurice T, Melnyk P.
    Med Chem; 2010 Nov; 6(6):355-73. PubMed ID: 20843289
    [Abstract] [Full Text] [Related]

  • 2. Tic hydantoin sigma-1 agonist: pharmacological characterization on cocaine-induced stimulant and appetitive effects.
    Toussaint M, Delair B, Foulon C, Lempereur N, Vaccher C, Maurice T, Melnyk P.
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):504-15. PubMed ID: 19249191
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective sigma1 ligands. Part 2.
    Cazenave Gassiot A, Charton J, Girault-Mizzi S, Gilleron P, Debreu-Fontaine MA, Sergheraert C, Melnyk P.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4828-32. PubMed ID: 16140009
    [Abstract] [Full Text] [Related]

  • 4. Sigma-1 ligands: Tic-hydantoin as a key pharmacophore.
    Toussaint M, Mousset D, Foulon C, Jacquemard U, Vaccher C, Melnyk P.
    Eur J Med Chem; 2010 Jan 01; 45(1):256-63. PubMed ID: 19875205
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and pharmacological evaluation of Tic-hydantoin derivatives as selective sigma1 ligands. Part 1.
    Charton J, Cazenave Gassiot A, Girault-Mizzi S, Debreu-Fontaine MA, Melnyk P, Sergheraert C.
    Bioorg Med Chem Lett; 2005 Nov 01; 15(21):4833-7. PubMed ID: 16140011
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of the stimulant and convulsant effects of cocaine by 17-substituted-3-hydroxy and 3-alkoxy derivatives of dextromethorphan.
    Zapata A, Gasior M, Geter-Douglass B, Tortella FC, Newman AH, Witkin JM.
    Pharmacol Biochem Behav; 2003 Jan 01; 74(2):313-23. PubMed ID: 12479950
    [Abstract] [Full Text] [Related]

  • 7. Sigma (σ) receptors as potential therapeutic targets to mitigate psychostimulant effects.
    Matsumoto RR, Nguyen L, Kaushal N, Robson MJ.
    Adv Pharmacol; 2014 Jan 01; 69():323-86. PubMed ID: 24484982
    [Abstract] [Full Text] [Related]

  • 8. Could sigma receptor ligands be a treatment for methamphetamine addiction?
    Rodvelt KR, Miller DK.
    Curr Drug Abuse Rev; 2010 Sep 01; 3(3):156-62. PubMed ID: 21054260
    [Abstract] [Full Text] [Related]

  • 9. N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice.
    Matsumoto RR, McCracken KA, Pouw B, Miller J, Bowen WD, Williams W, De Costa BR.
    Eur J Pharmacol; 2001 Jan 12; 411(3):261-73. PubMed ID: 11164383
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Involvement of sigma receptors in the behavioral effects of cocaine: evidence from novel ligands and antisense oligodeoxynucleotides.
    Matsumoto RR, McCracken KA, Pouw B, Zhang Y, Bowen WD.
    Neuropharmacology; 2002 Jun 12; 42(8):1043-55. PubMed ID: 12128006
    [Abstract] [Full Text] [Related]

  • 12. Involvement of the sigma1 receptor in the appetitive effects of cocaine.
    Maurice T, Romieu P.
    Pharmacopsychiatry; 2004 Nov 12; 37 Suppl 3():S198-207. PubMed ID: 15547786
    [Abstract] [Full Text] [Related]

  • 13. Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice.
    Tapia MA, Lever JR, Lever SZ, Will MJ, Park ES, Miller DK.
    Psychopharmacology (Berl); 2019 Nov 12; 236(11):3147-3158. PubMed ID: 31139878
    [Abstract] [Full Text] [Related]

  • 14. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals.
    Hashimoto K, Ishiwata K.
    Curr Pharm Des; 2006 Nov 12; 12(30):3857-76. PubMed ID: 17073684
    [Abstract] [Full Text] [Related]

  • 15. Sigma receptors: potential medications development target for anti-cocaine agents.
    Matsumoto RR, Liu Y, Lerner M, Howard EW, Brackett DJ.
    Eur J Pharmacol; 2003 May 23; 469(1-3):1-12. PubMed ID: 12782179
    [Abstract] [Full Text] [Related]

  • 16. Sigma ligand S14905 and locomotor activity in mice.
    Hascoet M, Bourin M, Payeur R, Lombet A, Peglion JL.
    Eur Neuropsychopharmacol; 1995 Dec 23; 5(4):481-9. PubMed ID: 8998401
    [Abstract] [Full Text] [Related]

  • 17. Selective sigma ligands block stimulant effects of cocaine.
    Menkel M, Terry P, Pontecorvo M, Katz JL, Witkin JM.
    Eur J Pharmacol; 1991 Aug 29; 201(2-3):251-2. PubMed ID: 1686761
    [No Abstract] [Full Text] [Related]

  • 18. A Role for Sigma Receptors in Stimulant Self-Administration and Addiction.
    Katz JL, Hiranita T, Hong WC, Job MO, McCurdy CR.
    Handb Exp Pharmacol; 2017 Aug 29; 244():177-218. PubMed ID: 28110353
    [Abstract] [Full Text] [Related]

  • 19. Effect of sigma ligands on the cocaine-induced convulsions in mice.
    Skuza G.
    Pol J Pharmacol; 1999 Aug 29; 51(6):477-83. PubMed ID: 10817525
    [Abstract] [Full Text] [Related]

  • 20. Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice.
    Sage AS, Oelrichs CE, Davis DC, Fan KH, Nahas RI, Lever SZ, Lever JR, Miller DK.
    Pharmacol Biochem Behav; 2013 Sep 29; 110():201-7. PubMed ID: 23891829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.